Effect of dolutegravir in combination with nucleoside reverse transcriptase inhibitors on people living with HIV who have pre-existing nucleoside reverse transcriptase inhibitor mutations
International Journal of Antimicrobial Agents | Jan 28, 2018
Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)
Urologic Oncology: Seminars and Original Investigations | Jan 28, 2018
T-cell papulosis associated with B-cell malignancy: A distinctive clinicopathologic entity
Journal of the European Academy of Dermatology and Venereology | Jan 28, 2018